Dasatinib + Quercetin (Senolytic Stack) vs Spermidine

Mechanism

Dasatinib is a multi-kinase inhibitor (targeting SRC, ABL, c-KIT, PDGFR, and ephrin receptors) originally developed for chronic myeloid leukemia. Quercetin is a natural flavonoid that inhibits PI3K, serpine/PAI-2, BCL-xL, and other anti-apoptotic pathways. Together, they constitute a senolytic combination that selectively induces apoptosis in senescent cells by disabling the senescent cell anti-apoptotic pathways (SCAPs) that allow damaged, non-dividing cells to resist programmed cell death. Senescent cells accumulate with aging and secrete the SASP (senescence-associated secretory phenotype) — inflammatory cytokines, matrix metalloproteinases, and growth factors that drive tissue dysfunction. By clearing senescent cells, D+Q reduces SASP-driven chronic inflammation.

Standard Dosing

Research indicates Dasatinib 100 mg + Quercetin 1000-1250 mg orally for 2 consecutive days, repeated every 2-4 weeks (intermittent 'hit-and-run' dosing).

Timing

Take both compounds together on dosing days, with or without food. The 'hit-and-run' approach exploits the fact that senolytic effect occurs rapidly but senescent cells take weeks to re-accumulate. Quercetin bioavailability is improved by fat co-ingestion.

Cycle Duration

Ongoing intermittent cycles. Long-term safety data in healthy populations is limited. Typically used in periodic courses (e.g., 2 days per month for 3-6 months, then reassess).

Side Effects

• GI discomfort, nausea, diarrhea (both compounds)
• Fluid retention and peripheral edema (dasatinib)
• Headache
• Thrombocytopenia and neutropenia (dasatinib — typically mild at senolytic doses)
• Pleural effusion (rare at intermittent dosing; more common with chronic oncology dosing)
• Skin rash

Contraindications

• Active bleeding disorders or thrombocytopenia
• Severe hepatic impairment
• Pulmonary arterial hypertension
• QT prolongation risk or concurrent QT-prolonging drugs
• Pregnancy and breastfeeding
• Active infections (temporary immunosuppression)

Best Stacking Partners

Mechanism

Spermidine is an endogenous polyamine that induces autophagy primarily through inhibition of the acetyltransferase EP300 (p300), leading to hypoacetylation of multiple autophagy-related proteins and subsequent activation of the core autophagy machinery (Atg5, Atg7, Beclin-1). It promotes mitophagy (selective clearance of damaged mitochondria) and is essential for the hypusination of eukaryotic translation initiation factor 5A (eIF5A), a post-translational modification critical for TFEB-mediated lysosomal biogenesis. Spermidine also reduces age-related inflammation by suppressing NF-kB signaling and promotes cardiovascular health through improved endothelial nitric oxide bioavailability.

Standard Dosing

Research indicates 1-6 mg/day orally for longevity and autophagy support. Epidemiological data associates >80 micromol/day dietary spermidine intake with reduced cardiovascular mortality.

Timing

Morning with or without food. Some protocols suggest taking before a fasting period to potentiate autophagy (fasting naturally increases endogenous spermidine synthesis).

Cycle Duration

Ongoing. Endogenous spermidine levels decline with aging, suggesting lifelong supplementation may be beneficial.

Side Effects

• Generally very well-tolerated
• Mild GI discomfort at higher doses
• Headache (rare)

Contraindications

• Known hypersensitivity to polyamines
• Pregnancy and breastfeeding (insufficient safety data at supplemental doses)
• Active malignancy (polyamines promote cell proliferation in rapidly dividing cells — debated)
• Wheat allergy (if from wheat germ source)

Best Stacking Partners